Cresomycin, a groundbreaking antibiotic developed by Harvard scientists, targets drug-resistant bacteria with improved binding to ribosomes, offering hope against global antimicrobial resistance. A new antibiotic…

Cresomycin, a groundbreaking antibiotic developed by Harvard scientists, targets drug-resistant bacteria with improved binding to ribosomes, offering hope against global antimicrobial resistance. A new antibiotic…
xAI owned by American tech billionaire Elon Musk, is set to release its latest chatbot, …